Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants
- PMID: 4027483
- PMCID: PMC1916522
- DOI: 10.1111/j.1476-5381.1985.tb10561.x
Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants
Abstract
The operational model of agonism (Black & Leff, 1983) has been used to analyse comparatively functional antagonism and irreversible antagonism as methods for estimating agonist dissociation constants (KAs). A general condition is established in terms of the model parameters which defines the type of experimental interventions at the receptor and the post-receptor level that allow valid KA estimation. It is shown that functional antagonism and other post-receptor interventions may produce changes in agonist-concentration effect curves which are qualitatively indistinguishable but quantitatively distinct, from those produced by irreversible antagonism. Experimental data obtained with the guinea-pig tracheal strip preparation are in keeping with the theoretical predictions and show how studies using functional antagonism may overestimate agonist affinity. In general, functional antagonism, unlike irreversible antagonism, is in principle an unreliable method for quantifying agonism.
Similar articles
-
An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.Br J Pharmacol. 1985 Feb;84(2):561-71. doi: 10.1111/j.1476-5381.1985.tb12941.x. Br J Pharmacol. 1985. PMID: 3978322 Free PMC article.
-
Estimation of partial agonist affinity by interaction with a full agonist: a direct operational model-fitting approach.Br J Pharmacol. 1993 Sep;110(1):239-44. doi: 10.1111/j.1476-5381.1993.tb13799.x. Br J Pharmacol. 1993. PMID: 8220884 Free PMC article.
-
Apparent activity of 5-methylfurmethide at muscarinic receptors.Arch Int Pharmacodyn Ther. 1980 Nov;248(1):69-75. Arch Int Pharmacodyn Ther. 1980. PMID: 7212878
-
Sensitization of effector responses by modification of agonist disposition mechanisms.Can J Physiol Pharmacol. 1976 Jun;54(3):177-87. doi: 10.1139/y76-030. Can J Physiol Pharmacol. 1976. PMID: 782671 Review.
-
From 'captive' agonism to insurmountable antagonism: demonstrating the power of analytical pharmacology.Clin Exp Pharmacol Physiol. 2001 Mar;28(3):223-9. doi: 10.1046/j.1440-1681.2001.03376.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11236130 Review.
Cited by
-
The classification of peripheral 5-HT2-like receptors using tryptamine agonist and antagonist analogues.Br J Pharmacol. 1986 Nov;89(3):493-9. doi: 10.1111/j.1476-5381.1986.tb11149.x. Br J Pharmacol. 1986. PMID: 3801784 Free PMC article.
-
Estimation of opioid receptor agonist dissociation constants with beta-chlornaltrexamine, an irreversible ligand which also displays agonism.Br J Pharmacol. 1988 Sep;95(1):234-40. doi: 10.1111/j.1476-5381.1988.tb16569.x. Br J Pharmacol. 1988. PMID: 2851350 Free PMC article.
-
Pharmacological analysis of the interaction between Bay K 8644 and 5-HT in rabbit aorta.Br J Pharmacol. 1986 Mar;87(3):487-94. doi: 10.1111/j.1476-5381.1986.tb10190.x. Br J Pharmacol. 1986. PMID: 2432977 Free PMC article.
-
Pharmacological analysis of the calcium-dependence of mu-receptor agonism.Br J Pharmacol. 1987 Dec;92(4):723-31. doi: 10.1111/j.1476-5381.1987.tb11376.x. Br J Pharmacol. 1987. PMID: 2827825 Free PMC article.
-
Modelling the changes induced by chronic desipramine treatment on the factors governing the agonism at prejunctional alpha 2-adrenoceptors.Br J Pharmacol. 1996 Mar;117(6):1286-92. doi: 10.1111/j.1476-5381.1996.tb16727.x. Br J Pharmacol. 1996. PMID: 8882627 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources